General information

Cohorts

Available compounds

Drug Tumor type Target Status
Cemiplimab  Cutaneous squamous cell carcinoma n.a. Inclusion is closed via DAP
Larotrectinib All NTRK gene fusions Open
Entrectinib All NTRK gene fusions Open
Selpercatinib Non-small cell lung cancer RET fusions Open
Selpercatinib Medullary thyroid cancer RET mutations Open
Capmatinib Non-small cell lung cancer MET exon 14 skipping mutations Closed
Tepotinib Non-small cell lung cancer MET exon 14 skipping mutations Open
Amivantamab Non-small cell lung cancer EGRF exon 20 insertion mutation Open